Kato D, Miyazawa K, Ruas M, Starborg M, Wada I, Oka T, Sakai T, Peters G, Hara E
Department of Preventive Medicine, Kyoto Prefectural University of Medicine, Japan.
FEBS Lett. 1998 May 8;427(2):203-8. doi: 10.1016/s0014-5793(98)00426-8.
The p16INK4A cyclin-dependent kinase (Cdk) inhibitor is now recognized as a major tumor suppressor that is inactivated by a variety of mechanisms in a wide range of human cancers. It is also implicated in the mechanisms underlying replicative senescence since p16INK4A RNA and protein accumulate as cells approach their proscribed limit of population doublings in tissue culture. To obtain further evidence of its role in senescence, we have sought ways of overexpressing p16INK4A in primary human diploid fibroblasts (HDF). To circumvent the low transfection efficiency of primary cells we have exploited a recombinant form of the full-length p16INK4A protein fused to a 16 amino acid peptide from the Drosophila antennapedia protein. This peptide has the capacity to cross both cytoplasmic and nuclear membranes allowing the direct introduction of the active protein to primary cells. Here, we show that antennapedia-tagged wild-type p16INK4A protein, but not a functionally compromised tumor-specific variant, causes G1 arrest in early passage HDFs by inhibiting the phosphorylation of the retinoblastoma protein. Significantly, the arrested cells display several phenotypic features that are considered characteristic of senescent cells. These data support a role for p16INK4A in replicative senescence and raise the possibility of using the antennapedia-tagged protein therapeutically.
p16INK4A细胞周期蛋白依赖性激酶(Cdk)抑制剂现在被认为是一种主要的肿瘤抑制因子,在多种人类癌症中通过多种机制失活。它还与复制性衰老的潜在机制有关,因为随着细胞在组织培养中接近其规定的群体倍增极限,p16INK4A RNA和蛋白质会积累。为了获得其在衰老中作用的进一步证据,我们寻求在原代人二倍体成纤维细胞(HDF)中过表达p16INK4A的方法。为了克服原代细胞转染效率低的问题,我们利用了一种重组形式的全长p16INK4A蛋白,该蛋白与果蝇触角足蛋白的16个氨基酸肽融合。这种肽具有穿过细胞质和核膜的能力,允许将活性蛋白直接引入原代细胞。在这里,我们表明,触角足蛋白标记的野生型p16INK4A蛋白,而不是功能受损的肿瘤特异性变体,通过抑制视网膜母细胞瘤蛋白的磷酸化,导致早期传代HDFs中的G1期阻滞。重要的是,停滞的细胞表现出几种被认为是衰老细胞特征的表型特征。这些数据支持p16INK4A在复制性衰老中的作用,并提高了使用触角足蛋白标记的蛋白进行治疗的可能性。